Early screening and lifestyle changes are key to preventing cancer cases

Every minute, 38 people are diagnosed with cancer, and 18 people die from it globally, according to the World Health Organization, and it’s estimated to increase by 77% to 35 million in 2050. But what if we could predict cancer risks before they even develop? Genetic testing helps detect cancer risks early, making it essential for cancer prevention and control.
Read More

Light-activated compound offers hope for overcoming drug resistance in cancer treatment

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using light. Professors Tae-Hyuk Kwon and Duyoung Min from the Department of Chemistry at UNIST, alongside Professor Taiho Park from POSTECH, have created a photoreactive compound capable of suppressing autophagy in cancer cells—one of the key mechanisms contributing to resistance against anticancer therapies.
Read More

Opioid delta-receptor agonists alleviate stress-induced irritable bowel syndrome symptoms in mouse model

Irritable bowel syndrome (IBS) is a common digestive disorder that affects the intestine, causing symptoms such as abdominal pain, bloating, gas, and changes in bowel habits, including diarrhea, constipation, or both. Although this condition affects about a tenth of the global population, the underlying causes and mechanisms of IBS remain unclear. Consequently, treatments for IBS primarily focus on managing symptoms rather than addressing the root cause of the disorder.
Read More
Top